634 related articles for article (PubMed ID: 26745681)
41. FFAR4 (GPR120) Signaling Is Not Required for Anti-Inflammatory and Insulin-Sensitizing Effects of Omega-3 Fatty Acids.
Pærregaard SI; Agerholm M; Serup AK; Ma T; Kiens B; Madsen L; Kristiansen K; Jensen BA
Mediators Inflamm; 2016; 2016():1536047. PubMed ID: 27999451
[TBL] [Abstract][Full Text] [Related]
42. Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids.
Rogero MM; Calder PC
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29601492
[TBL] [Abstract][Full Text] [Related]
43. Association between polyunsaturated fatty acids and inflammatory markers in patients in secondary prevention of cardiovascular disease.
Bersch-Ferreira ÂC; Sampaio GR; Gehringer MO; Ross-Fernandes MB; Kovacs C; Alves R; Pereira JL; Magnoni CD; Weber B; Rogero MM
Nutrition; 2017 May; 37():30-36. PubMed ID: 28359359
[TBL] [Abstract][Full Text] [Related]
44. Breastmilk with a high omega-6 to omega-3 fatty acid ratio induced cellular events similar to insulin resistance and obesity in 3T3-L1 adipocytes.
Vaidya H; Cheema SK
Pediatr Obes; 2018 May; 13(5):285-291. PubMed ID: 28335075
[TBL] [Abstract][Full Text] [Related]
45. Impact of the omega-3 to omega-6 polyunsaturated fatty acid ratio on cytokine release in human alveolar cells.
Cotogni P; Muzio G; Trombetta A; Ranieri VM; Canuto RA
JPEN J Parenter Enteral Nutr; 2011 Jan; 35(1):114-21. PubMed ID: 21224438
[TBL] [Abstract][Full Text] [Related]
46. Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future.
Watanabe Y; Tatsuno I
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):865-873. PubMed ID: 28531360
[TBL] [Abstract][Full Text] [Related]
47. Association of n-3 polyunsaturated fatty acids and inflammatory indicators with renal function decline in type 2 diabetes.
Chung HF; Long KZ; Hsu CC; Al Mamun A; Jhang HR; Shin SJ; Hwang SJ; Huang MC
Clin Nutr; 2015 Apr; 34(2):229-34. PubMed ID: 24721145
[TBL] [Abstract][Full Text] [Related]
48. Effects of ω-3 Polyunsaturated Fatty Acids on the Homeostasis of CD4+ T Cells and Lung Injury in Mice With Polymicrobial Sepsis.
Chang YF; Hou YC; Pai MH; Yeh SL; Liu JJ
JPEN J Parenter Enteral Nutr; 2017 Jul; 41(5):805-814. PubMed ID: 26231059
[TBL] [Abstract][Full Text] [Related]
49. Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction.
Liu QK
J Clin Lipidol; 2021; 15(4):556-568. PubMed ID: 34172393
[TBL] [Abstract][Full Text] [Related]
50. Corn oil versus lard: Metabolic effects of omega-3 fatty acids in mice fed obesogenic diets with different fatty acid composition.
Pavlisova J; Bardova K; Stankova B; Tvrzicka E; Kopecky J; Rossmeisl M
Biochimie; 2016 May; 124():150-162. PubMed ID: 26151346
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
Schunck WH; Konkel A; Fischer R; Weylandt KH
Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
[TBL] [Abstract][Full Text] [Related]
52. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study.
Griffin BA
Curr Opin Lipidol; 2008 Feb; 19(1):57-62. PubMed ID: 18196988
[TBL] [Abstract][Full Text] [Related]
53. ω3-polyunsaturated fatty acids suppress lipoprotein-associated phospholipase A2 expression in macrophages and animal models.
Li Z; Ren W; Han X; Liu X; Wang G; Zhang M; Pang D; Ouyang H; Tang X
Mol Nutr Food Res; 2015 Sep; 59(9):1771-9. PubMed ID: 26018800
[TBL] [Abstract][Full Text] [Related]
54. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review.
Saini RK; Keum YS
Life Sci; 2018 Jun; 203():255-267. PubMed ID: 29715470
[TBL] [Abstract][Full Text] [Related]
55. Polyunsaturated fatty acids as antioxidants.
Richard D; Kefi K; Barbe U; Bausero P; Visioli F
Pharmacol Res; 2008 Jun; 57(6):451-5. PubMed ID: 18583147
[TBL] [Abstract][Full Text] [Related]
56. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome.
Tousoulis D; Plastiras A; Siasos G; Oikonomou E; Verveniotis A; Kokkou E; Maniatis K; Gouliopoulos N; Miliou A; Paraskevopoulos T; Stefanadis C
Atherosclerosis; 2014 Jan; 232(1):10-6. PubMed ID: 24401211
[TBL] [Abstract][Full Text] [Related]
57. Omega-3 to omega-6 fatty acid oxidation ratio as a novel inflammation resolution marker for metabolic complications in obesity.
Sarajlic P; Vigor C; Avignon A; Zhou B; Oger C; Galano JM; Durand T; Sultan A; Bäck M
Nutr Metab Cardiovasc Dis; 2023 Jun; 33(6):1206-1213. PubMed ID: 37032252
[TBL] [Abstract][Full Text] [Related]
58. Omega-3 fatty acids and inflammatory processes: from molecules to man.
Calder PC
Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
[TBL] [Abstract][Full Text] [Related]
59. Reverse association of omega-3/omega-6 polyunsaturated fatty acids ratios with carotid atherosclerosis in patients on hemodialysis.
Umemoto N; Ishii H; Kamoi D; Aoyama T; Sakakibara T; Takahashi H; Tanaka A; Yasuda Y; Suzuki S; Matsubara T; Murohara T
Atherosclerosis; 2016 Jun; 249():65-9. PubMed ID: 27065243
[TBL] [Abstract][Full Text] [Related]
60. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases.
Simopoulos AP
Biomed Pharmacother; 2006 Nov; 60(9):502-7. PubMed ID: 17045449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
